About Event

The Only East Coast Forum Dedicated to Shaping a Sustainable Future for Pharma, Biotech, Medtech & Life Sciences Service Providers

Whether you're joining us for the first time or returning as part of our growing community, the 4th ESG in Life Sciences Summit East is your essential platform to stay ahead of the evolving ESG landscape in the life sciences sector.

This one-of-a-kind event brings together East Coast leaders in ESG, Sustainability, Corporate Responsibility, Procurement, Supply Chain, and Finance from some of the industry’s most influential organizations - including Thermo Fisher Scientific, Medtronic, Biogen, Sonic Healthcare, and many more.

Here, you’ll connect with the key opinion leaders actively driving ESG strategy and implementation across life sciences, and gain fresh, practical insights into how the industry is tackling complex and urgent challenges - from supply chain emissions and regulatory shifts to embedding ESG into your company's DNA and sustainable innovation.

Conference Image

Spanning three days of case studies, industry discussions, and workshops, the agenda tackles today’s most urgent ESG priorities. Join the summit to:

discover

Discover how Medtronic, Biogen, and Takeda are embedding ESG across core business functions to drive accountability, accelerate change, and build lasting internal ownership - transforming ESG from a 'nice to have' into a business-critical priority

explore

Explore how Bio-Techne Corporation and Medtronic are turning ESG into commercial value - strengthening corporate strategy, securing executive buy-in, and moving beyond compliance toward competitive advantage

learn (1)

Learn how Blueprint Medicines, STgenetics, and Integra LifeSciences are evolving ESG strategies in response to shifting US and EU regulations, political turbulence, and global uncertainty - without losing momentum or clarity of purpose

hear

Hear how Grifols, Legend Biotech, Teleflex, and Biogen are preparing for EU reporting in the interim - featuring lessons from Wave 1 reporters on managing CSRD delays, building reporting resilience, and avoiding costly pitfalls

see

See how Merck, Thermo Fisher Scientific, Sonic Healthcare, and others are tackling Scope 3 and product-level emissions with scalable, cost-effective solutions - supporting cross-functional progress across R&D, procurement, and supplier networks